276 related articles for article (PubMed ID: 22584705)
1. Pituitary tumors in patients with MEN1 syndrome.
Syro LV; Scheithauer BW; Kovacs K; Toledo RA; Londoño FJ; Ortiz LD; Rotondo F; Horvath E; Uribe H
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):43-8. PubMed ID: 22584705
[TBL] [Abstract][Full Text] [Related]
2. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
3. Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation.
Lips CJ; Dreijerink KM; Höppener JW
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):49-56. PubMed ID: 22584706
[TBL] [Abstract][Full Text] [Related]
4. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.
Tanaka C; Yoshimoto K; Yamada S; Nishioka H; Ii S; Moritani M; Yamaoka T; Itakura M
J Clin Endocrinol Metab; 1998 Mar; 83(3):960-5. PubMed ID: 9506756
[TBL] [Abstract][Full Text] [Related]
5. [Pituitary pathology and MEN 1].
Betea D; Valdes Socin H; Beckers A
Ann Endocrinol (Paris); 2000 Sep; 61(3):214-23. PubMed ID: 10970947
[TBL] [Abstract][Full Text] [Related]
6. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.
Stratakis CA; Schussheim DH; Freedman SM; Keil MF; Pack SD; Agarwal SK; Skarulis MC; Weil RJ; Lubensky IA; Zhuang Z; Oldfield EH; Marx SJ
J Clin Endocrinol Metab; 2000 Dec; 85(12):4776-80. PubMed ID: 11134142
[TBL] [Abstract][Full Text] [Related]
7. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
Beckers A; Daly AF
Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
[TBL] [Abstract][Full Text] [Related]
8. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the MEN1 gene in sporadic pituitary adenomas from Japanese patients.
Fukino K; Kitamura Y; Sanno N; Teramoto A; Emi M
Cancer Lett; 1999 Sep; 144(1):85-92. PubMed ID: 10503881
[TBL] [Abstract][Full Text] [Related]
10. Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.
Daly AF; Tichomirowa MA; Beckers A
Horm Res; 2009 Jan; 71 Suppl 1():105-11. PubMed ID: 19153518
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in MEN1 gene study for pituitary tumor pathogenesis.
Kameya T; Tsukada T; Yamaguchi K
Front Horm Res; 2004; 32():265-91. PubMed ID: 15281352
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
[TBL] [Abstract][Full Text] [Related]
13. MEN1 and pituitary adenomas.
Delemer B
Ann Endocrinol (Paris); 2012 Apr; 73(2):59-61. PubMed ID: 22542456
[TBL] [Abstract][Full Text] [Related]
14. Pluripotent tumor cells in benign pituitary adenomas associated with multiple endocrine neoplasia type 1.
Weil RJ; Huang S; Pack S; Vortmeyer AO; Tsokos M; Lubensky IA; Oldfield EH; Zhuang Z
Cancer Res; 1998 Oct; 58(20):4715-20. PubMed ID: 9788627
[TBL] [Abstract][Full Text] [Related]
15. Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.
Evans CO; Brown MR; Parks JS; Oyesiku NM
J Endocrinol Invest; 2000 May; 23(5):304-9. PubMed ID: 10882148
[TBL] [Abstract][Full Text] [Related]
16. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic features of familial pituitary adenomas.
Daly AF; Jaffrain-Rea ML; Beckers A
Horm Metab Res; 2005 Jun; 37(6):347-54. PubMed ID: 16001326
[TBL] [Abstract][Full Text] [Related]
18. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
[TBL] [Abstract][Full Text] [Related]
19. Sporadic pituitary adenoma with somatic double-hit loss of MEN1.
Hong CS; Alanya H; DiStasio M; Boulware SD; Rimmer RA; Omay SB; Erson-Omay EZ
Pituitary; 2023 Aug; 26(4):488-494. PubMed ID: 37438451
[TBL] [Abstract][Full Text] [Related]
20. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
